Navigation Links
Roper Industries Announces Record First Quarter Results

SARASOTA, Fla., April 26, 2011 /PRNewswire/ -- Roper Industries, Inc.  (NYSE: ROP) reported financial results for the first quarter ended March 31, 2011.

Diluted earnings per share were $0.91, as net earnings for the first quarter reached $89 million, a 49% increase over the first quarter of 2010.  Sales increased 21% to $645 million and orders increased 24% to an all-time record of $702 million.  

Operating income was $142 million, representing 22% of sales, an increase of 320 basis points over the prior year.  EBITDA reached $177 million and EBITDA margin expanded 310 basis points to a record 27.4% of sales.  

"Roper is off to a great start in 2011 with organic sales growth of 16% and orders that exceeded our expectations," said Brian Jellison, Roper's Chairman, President and CEO.  "We are encouraged by broad-based strength across all four of our segments, as each posted double-digit sales and orders growth.  As a result of strong operating leverage and exceptional execution by our businesses, we were able to expand both gross margin by 200 basis points and operating margin by 320 basis points in the quarter."

"With another solid quarter of cash generation, we reduced our outstanding debt by nearly $100 million, bringing net-debt-to-net capitalization to 25% and providing the Company with over $800 million in available liquidity.  Our acquisition pipeline is full and we see interesting opportunities for the remainder of the year," Mr. Jellison continued.

2011 Outlook and Guidance"We are well positioned for the balance of 2011 with a record backlog of $851 million and a first quarter book-to-bill ratio of 1.09," said Mr. Jellison.  

Roper is increasing its full year DEPS guidance to $3.97 - $4.12 from $3.82 - $4.02, and establishing second quarter DEPS guidance of $0.95 - $1.00.  The Company's guidance excludes future acquisitions. Table 1:  Sales GrowthQ1 2011Total Sales Growth

21%Acquisitions / Divestitures

4%Foreign Currency


16%Table 2:  EBITDA and EBITDA MarginQ1 2011Q1 2010Net Earnings

$89.0$59.7Add:  Interest Expense

16.716.2Add:  Income Taxes

37.025.3Add:  Depreciation & Amortization

34.328.5EBITDA (A)

$177.0$129.7Revenue (B)

$645.3$534.4EBITDA Margin (A)/(B)

27.4%24.3%Conference Call to be Held at 8:00 AM (ET) TodayA conference call to discuss these results has been scheduled for 8:00 AM ET on Tuesday, April 26, 2011.  The call can be accessed via webcast or by dialing +1 800-967-7134 (US/Canada) or +1 719-457-2639, using confirmation code 5338709.  Webcast information and conference call materials will be made available in the Investors section of Roper's website ( prior to the start of the call.  Telephonic replays will be available for up to two weeks by calling +1 (719) 457-0820 and using the access code 5338709.

About Roper IndustriesRoper Industries is a market-driven, diversified growth company and is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper provides engineered products and solutions for global niche markets, including water, energy, radio frequency and research/medical applications.  Additional information about Roper Industries is available on the Company's website at

The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward looking statements include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth and profit expectations.  Forward looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases.  These statements reflect management's current beliefs and are not guarantees of future performance.  They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to integrate our acquisitions and realize expected synergies.  We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions, unfavorable changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, difficulties in making and integrating acquisitions, risks associated with newly acquired businesses, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, environmental compliance costs and liabilities, risks and cost associated with asbestos related litigation and potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products.  Important risks may be discussed in current and subsequent filings with the SEC.  You should not place undue reliance on any forward-looking statements.  These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.

Roper Industries, Inc. and SubsidiariesCondensed Consolidated Balance Sheets (unaudited)(Amounts in thousands)March 31,December 31,ASSETS20112010CURRENT ASSETS:  Cash and cash equivalents

270,394  Accounts receivable

413,371403,337  Inventories

198,788178,559  Unbilled receivable

79,07275,620  Deferred taxes

33,83432,894  Other current assets

43,12837,287Total current assets


103,639103,487OTHER ASSETS:  Goodwill

2,748,5102,727,780  Other intangible assets, net

1,083,4821,104,513  Deferred taxes

55,62957,850  Other assets

75,99477,803Total other assets

3,963,6153,967,946TOTAL ASSETS

$ 5,096,894$

37,778  Accrued liabilities

268,036298,080  Income taxes payable

--  Deferred taxes

10,66410,445  Current portion of long-term debt

81,82693,342Total current liabilities

507,541539,645NONCURRENT LIABILITIES:  Long-term debt

1,159,9611,247,703  Deferred taxes

474,185465,001  Other liabilities

73,07866,268Total liabilities

2,214,7652,318,617STOCKHOLDERS' EQUITY:  Common stock

977971  Additional paid-in capital

1,060,7851,045,286  Retained earnings

1,759,2821,680,849  Accumulated other comprehensive earnings

81,18843,978  Treasury stock

(20,103)(20,177)Total stockholders' equity


$ 5,096,894$
5,069,524Roper Industries, Inc. and SubsidiariesCondensed Consolidated Statements of Earnings (unaudited)(Amounts in thousands, except per share data)Three months endedMarch 31,20112010Net sales

$ 645,309$ 534,441Cost of sales

295,213254,876Gross profit

350,096279,565Selling, general and administrative expenses

208,096178,849Income from operations

142,000100,716Interest expense

16,69616,181Other income

711447Earnings from continuing operations before   income taxes

126,01584,982Income taxes

37,03625,257Net Earnings

$   88,979$   59,725Earnings per share:  Basic

.64  Diluted

.62Weighted average common and common  equivalent shares outstanding:Basic


98,15396,036Roper Industries, Inc. and SubsidiariesSelected Segment Financial Data (unaudited)(Amounts in thousands and percents of net sales)Three months ended March 31,20112010Amount%Amount%Net sales:  Industrial Technology

$ 169,982$ 135,312  Energy Systems & Controls

129,633105,678  Medical & Scientific Imaging

145,287130,244  RF Technology


$ 645,309$ 534,441Gross profit:  Industrial Technology

$   85,71450.4%$   67,51249.9%  Energy Systems & Controls

70,14654.1%53,49150.6%  Medical & Scientific Imaging

91,25462.8%77,51059.5%  RF Technology


$ 350,09654.3%$ 279,56552.3%Operating profit*:  Industrial Technology

$   46,18927.2%$   31,76623.5%  Energy Systems & Controls

29,04422.4%18,92317.9%  Medical & Scientific Imaging

35,03724.1%29,33422.5%  RF Technology


$ 155,22024.1%$ 112,22421.0%Net Orders:  Industrial Technology

$ 200,742$ 154,093  Energy Systems & Controls

134,205115,300  Medical & Scientific Imaging

150,265131,110  RF Technology


$ 702,299$ 567,246  *  Operating profit is before unallocated corporate general and administrative expenses.  These expenses were $13,220 and $11,508 for the three months ended March 31, 2011 and 2010, respectively.Roper Industries, Inc. and SubsidiariesCondensed Consolidated Statements of Cash Flows (unaudited)(Amounts in thousands)Three months endedMarch 31,20112010Net earnings

$  88,979$  59,725Non-cash items:Depreciation


25,05419,095Stock-based compensation expense

8,1127,008Income taxes

3,42411,353Changes in assets and liabilities:Receivables


(16,359)(2,344)Accounts payable

6,85412,901Accrued liabilities

(23,466)(24,762)Other, net

2,911(80)  Cash provided by operating activities

86,58495,086Business acquisitions, net of cash acquired

-(15,000)Capital expenditures

(8,813)(6,485)Other, net

(198)2,841  Cash used by investing activities

(9,011)(18,644)Principal debt borrowings

--Principal debt payments

(11,968)(2,999)Revolver borrowings (payments), net

(85,000)(40,000)Debt issuance costs


(10,458)(8,878)Excess tax benefit from share-based payment

2,8551,021Proceeds from exercise of stock options

8,6072,443Other, net

(118)366  Cash used by financing activities

(96,082)(48,047)Effect of exchange rate changes on cash

9,562(4,818)Net increase (decrease) in cash and equivalents

(8,947)23,577Cash and equivalents, beginning of period

270,394167,708Cash and equivalents, end of period


SOURCE Roper Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Roper Industries Reschedules First Quarter 2011 Financial Results Conference Call
2. McDonald Hopkins Law Firm Alert: Recent Court of Appeals Decision Highlights the Need to Properly Define the Role of Sales Representatives
3. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
4. ERT to Change Trading Symbol to "ERT" Effective March 7, 2011 to Properly Align Business Brand
5. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
6. 75 Percent of Hospital IT Leaders View Interoperability Between Vendor Systems as Critical to Operational Effectiveness in Healthcare Settings
7. Omnicell is First to Demonstrate Automated Dispensing Cabinet Interoperability at HIMSS11 Showcase
8. OnBase Proves Value of ECM Software in Achieving Interoperability in Healthcare
9. Recent Study Demonstrates Anti-Inflammatory Properties of Oligonol® Lychee Fruit Polyphenols in Humans
10. Effective Treatment of Lyme Disease-Related Arthritis Depends on Proper Diagnosis
11. Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase
Post Your Comments:
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):